The 2020 version of the diabetes prevention and control guidelines is released, these 5 major updates should be known (drug treatment)

*Only for medical professionals to read the new choice of lipid-lowering drugs, know it! In April 2021, the "China Type 2 Diabetes Prevention Guidelines (2020 Edition)" formulated by the Diabetes Branch of the Chinese Medical Association was officially released.

Regarding the drug treatment of type 2 diabetes, the five major updated points of the new version of the guidelines are as follows: Point 1: Five drugs can be used for pre-diabetes intervention pre-diabetes including impaired fasting blood glucose (IFG), impaired glucose tolerance (IGT) or both .

The hypoglycemic drugs metformin, α-glycosidase inhibitors, thiazolidinedione drugs, glucagon-like peptide-1 (GLP-1) receptor agonists, and weight-loss drugs orlistat can all reduce pre-diabetes The risk of diabetes in the population.

After 6 months of intensive life>
Among them, the long-term safety evidence of metformin and acarbose in the pre-diabetic population is relatively sufficient.

Attachment: Diagnostic criteria for type 2 diabetes